MPMichael Aleksandrovich Piradov

Michael Aleksandrovich Piradov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Recognitions

Top Cited Scholar (2026)

Michael Aleksandrovich Piradov has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Phenotypical heterogenity of cerebral atherosclerosis: clinical, biochemical and epigenetic associations

    by A. A. Raskurazhev, M. M. Tanashyan, A. A. Shabalina, P. I. Kuznetsova, M. A. Piradov, А. А. Раскуражев, М. М. Танашян, А. А. Шабалина, П. И. Кузнецова, М. А. Пирадов

    Background. Cerebral atherosclerosis is one of the leading causes of ischemic stroke and shows marked clinical and molecular heterogeneity. Conventional laboratory parameters do not always adequately reflect atherosclerotic burden and disease activity, highlighting the need for novel epigenetic and molecular-genetic markers of atherogenesis. Aim: to identify clinical and molecular phenotypes of cerebral atherosclerosis based on the integrated analysis of clinical data and the expression of microRNAs and atherosclerosis-associated genes. Material and methods. Eighty patients with cerebral atherosclerosis (median age 66 years) were enrolled in this prospective study. Leukocyte expression of 8 microRNAs (miR-126, miR-29, miR-33a, miR-21 families) was assessed by Real-time PCR, and 54 cardiovascular panel genes were profiled with the nanoString nCounter platform. Differential expression, correlation (Spearman with FDR correction), cluster (FAMD/HCPC), and co-expression network analyses were performed. Results. Differential expression of miR-126-3p/-5p, miR-29-3p, miR-33a-5p/-3p, and miR-21-3p was demonstrated according to the severity of carotid stenosis, alongside overexpression of 6 genes (ABCA7, MTHFR, TNF, PLEKHG1, SORL1, CCDC127) in patients with ICA stenosis ≥ 70%. Significant inverse correlations between miR-126 and proatherogenic genes were established. Cluster analysis identifi ed 4 clinical and molecular phenotypes — “endothelioprotective/early”, “moderate/reference”, “systemic atherosclerotic”, and “cerebrometabolic” — refl ecting the continuum of disease progression. Conclusion. The study confirmed the clinical and molecular heterogeneity of cerebral atherosclerosis with the identifi cation of four distinct phenotypes reflecting different trajectories of disease progression. These findings may serve as a basis for personalized approaches to risk stratification, diagnosis, and treatment of patients with cerebrovascular disease.

  • Open Access

    Early outcomes of treatment in patients with essential tremor using magnetic resonance-guided focused ultrasound

    by V. A. Ovchinnikov, V. M. Tyurnikov, A. S. Simonyan, V. M. Akinfiev, O. O. Kamadey, А. S. Filatov, A. O. Gushcha, V. V. Krylov, M. А. Piradov, В. А. Овчинников, et al.

    Background. Essential tremor is one of the most common movement disorders, significantly impairing patients’ quality of life. In recent years, focused ultrasound thalamotomy has been considered a minimally invasive alternative to conventional surgical treatment methods. Aim. To evaluate the clinical efficacy and safety of magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy in patients with medication-refractory essential tremor. Materials and methods. The study included 22 patients with essential tremor who underwent unilateral treatment using MRgFUS. Efficacy was assessed using the Clinical Rating Scale for Tremor (CRST; total score and subscales A, B, and C) preoperatively, and at 1 day, 3 months, and 6 months post-intervention. Safety was evaluated based on the incidence and progression of adverse events. Statistical analysis was performed using IBM SPSS Statistics 26.0, applying both parametric and non-parametric tests; the level of significance was set at p Results. As early as 1 day postoperatively, a statistically significant reduction in the mean total CRST score was observed, amounting to 57.6 %. Reductions in subscale scores were as follows: part A – 58.3 %, part B – 49.3 %, and part C – 68.0 %. At 6 months, the mean reduction in the total CRST score remained at 51.9 % compared to baseline values; reductions in part A, part B, and part C were 52.7 %, 42.9 %, and 63.1 %, respectively. The most frequently reported adverse events included gait imbalance (40.9 %), contralateral sensory disturbances (13.63 %), and contralateral motor disturbances (13.63 %), with their incidence gradually decreasing by the 6-month follow-up. Tremor recurrence was observed in 9.09 % of patients. Conclusion. MRgFUS thalamotomy is an effective and safe treatment modality for medication-refractory essential tremor. The obtained results are consistent with data reported in the international literature and support the potential of this technique for broader clinical application.

  • Open Access

    Assessment of Comorbidity in Patients with Chronic Disorders of Consciousness

    by L. A. Legostaeva, N. A. Suponeva, O. A. Kirichenko, D. V. Sergeev, K. A. Yatsko, A. D. Kolokoltsev, A. A. Bormin, Yu. V. Ryabinkina, M. A. Piradov, Л. А. Легостаева, et al.

    Presence and decompensation of comorbid conditions can directly affect levels of wakefulness and cosciousness in patients with chronic disorders of consciousness (DoC). Identifying and thorough assessment of comorbid conditions and concurrent diseases is a decisive step in diagnosing signs of consciousness, monitoring changes over time, and making prognoses in patients with DoC. Objective . To assess the incidence and severity of comorbid conditions in patients with chronic DoC using the Comorbidities Coma Scale (CoCoS). Materials and Methods. At the Russian Center of Neurology and Neurosciences, we conducted a retrospective review of the medical records of 52 patients with chronic DoC of various etiologies (31 men, 21 women; traumatic etiology, n = 18; non-traumatic etiology, n = 34). To determine the type of DoC, all patients were independently assessed twice by two investigators using the Coma Recovery Scale–Revised (CRS-R). To account for the severity and nature of brain injury, we analyzed etiology (traumatic/non-traumatic), time since injury, and the baseline CRS-R score as an integrated measure of neurological deficit. Comorbid status was assessed using the CoCoS scale. Results . Different types of stomas as life-sustaining medical devices (tracheostomy, gastrostomy, and suprapubic cystostomy) in 100%, and joint disorders in 98% were identified as predominant comorbid conditions in patients with chronic DoC. Less common comorbid conditions included urinary tract infections (71.15%), kidney diseases (57.69%), pressure ulcers (53.85%), infectious respiratory diseases (46.15%), malnutrition (38.46%), anemia (30.77%), fractures of bones and skull (28.85%), hydrocephalus (13.46%), and paroxysmal autonomic activity (13.25%). Сomorbidity of moderate severity was identified in one patient (1.96%); all others were classified as mild. When stratified by etiology, no significant differences in the total CoCoS score were found between the traumatic and non-traumatic groups (p > 0.05). No correlation was observed between CRS-R and CoCoS scores in the overall sample (p = 0.051, R = 0.227); similar results were obtained in the subgroup analyses (traumatic: p = 0.43, R = 0.19; non-traumatic: p = 0.28, R = 0.21). Conclusion . The analysis revealed a high prevalence of medical devices used to support vital functions and prevent joint contractures, reflecting apparent dependence of patients with chronic DoC on technical support and care. In most cases, the comorbidity burden was mild, indicating a relatively compensated somatic status. The absence of a significant correlation between the level of consciousness and comorbidity burden suggests that, in cases of mild comorbidity, somatic disorders are not the determining factor masking conscious activity. These findings underscore the need for an interdisciplinary approach to the management of such patients and the mandatory quantitative assessment of structural brain damage, otherwise it is impossible to distinguish the contribution of primary brain injury from that of concomitant pathology into development of chronic DoC.

  • Open Access

    HIF-2α Depletion and HIF-1α Overexpression in Vulnerable Brain Regions Distinguish Alzheimer’s Disease with Cerebral Amyloid Angiopathy

    by Vladimir S. Sukhorukov, Tatiana I. Baranich, Olga V. Velts, Kseniia M. Okulova, Dmitry N. Voronkov, Ekaterina V. Shcherbak, Anna V. Egorova, Natalia M. Mudzhiri, Dmitry S. Lazarev, Alexander P. Raksha, et al.

    Hypoxia-inducible factors (HIF-1α, HIF-2α, HIF-3α) regulate cellular adaptation to oxygen deprivation, but their region-specific roles in Alzheimer’s disease (AD) and AD with cerebral amyloid angiopathy (CAA) remain unclear. Using post-mortem human brain tissue from aging, AD, and AD + CAA groups, we measured all three HIF isoforms in hippocampal subfields (CA1, CA2, CA4, dentate gyrus) and anterior cingulate cortex (ACC) layers 3 and 5. In the AD hippocampus, two distinct patterns emerged: ischemia-resistant regions (CA4, DG) maintained HIF-2α and showed relative resilience, whereas vulnerable regions (CA1, CA2) exhibited HIF-1α upregulation, HIF-3α loss, and HIF-2α dysregulation. The ACC contrasts sharply with the hippocampus by preserving coordinated HIF-1α/HIF-3α regulation during aging and AD, with layer-specific divergence (exhaustion in layer 3 vs. resilience in layer 5) emerging only upon addition of CAA. Notably, HIF-2α in ACC neurons remains stably elevated across all conditions. Taken together, our results highlight HIF-2α as a potential contributor to regional vulnerability and raise the possibility that maintaining HIF-2α levels, in addition to or instead of modulating HIF-1α, could be worthy of further investigation in the context of AD and related vascular changes.

  • Open Access

    Scale for the Assessment and Rating of Ataxia (SARA): linguistic and cultural adaptation of the Russian-language version with an assessment of psychometric properties

    by O. A. Kirichenko, Кириченко О. А., E. P. Nuzhnyy, Нужный Е. П., A. A. Zimin, Зимин А. А., A. E. Slotina, Слотина А. Е., S. A. Klyushnikov, Клюшников С. А., et al.

    Background. The clinical presentation of ataxia includes a wide range of symptoms, the severity of which increases with disease progression. Standardized clinical assessment tools enable the evaluation of disease severity and monitoring of its progression. The Scale for the Assessment and Rating of Ataxia (SARA) is a sufficiently simple and accurate tool for examining patients with various forms of ataxia. However, the use of this scale in the Russian Federation is limited because a validated Russian-language version is not available. Aim. A linguacultural adaptation of the original version of SARA with an assessment of the psychometric properties of the created official Russian-language version. Materials and methods. This study included 60 patients with hereditary cerebellar ataxias, with a median age of 48 [39.3–58.8] years. During the first stage, a linguacultural adaptation of the original English version of the scale was performed following standard guidelines. During the second stage of the validation study, we assessed the psychometric properties of the Russian-language version of the scale: reliability, content validity, and sensitivity. Results. The resulting Russian-language version of the SARA scale demonstrated a high levels of reliability, sensitivity, and validity. Conclusion. A validated Russian-language version of the SARA is presented and recommended for use in clinical practice and research by Russian-speaking specialists.


  • Open Access

    Evolution of the approaches to target identification for therapeutic repetitive transcranial magnetic stimulation

    by Ilya S. Bakulin, Alexandra G. Poydasheva, Dmitry O. Sinitsyn, Anastasia N. Sergeeva, Alfiia Kh. Zabirova, Dmitry Yu. Lagoda, Dmitry V. Sergeev, Natalia A. Suponeva, Michael A. Piradov, Пойдашева Александра Георгиевна, et al.

    Repetitive transcranial magnetic stimulation (rTMS) has been widely used in clinical practice for therapeutic neuromodulation in a number of nervous system disorders. However, current application of this method is limited primarily by its small effect size and high variability. Among promising research directions for improving rTMS efficacy, novel approaches to target identification hold particular importance. Standard approaches involve selecting relatively large anatomical cortical areas as targets, with coil positioning based on external landmarks or craniometric measurements. However, these methods often fail to target the intended cortical area, or account for individual variations in cortical gyral anatomy and functional area localization. Neuronavigation allows high-precision positioning of the coil on the head surface relative to the cortical target based on structural and functional neuroimaging data. In recent years, approaches to rTMS target identification based on resting-state fMRI data have been particularly intensively developed; analysis of such data enables identification of areas with altered connectivity and localization of neuronal network nodes. This enables personalized determination of rTMS targets. This review discusses the main approaches to rTMS target identification, their methodological features, evidence base, key advantages, and limitations. The role of navigation for determining optimal coil orientation relative to the target cortical area and selecting stimulation intensity is separately addressed.

  • Open Access

    Quadripulse stimulation – a promising patterned repetitive transcranial magnetic stimulation protocol

    by Ilya S. Bakulin, A. R. Relina, A. G. Poydasheva, A. Kh. Zabirova, D. Yu. Lagoda, N. A. Suponeva, M. A. Piradov

    Quadripulse stimulation (QPS) is a relatively new and highly promising repetitive transcranial magnetic stimulation protocol. QPS is based on the application of bursts, consisting of 4 monophasic stimuli with a very short interstimulus interval (5 or 50 ms, QPS 5 and QPS50, respectively), which are repeated every 5 seconds. Long-term neuromodulating effects of QPS protocols are bi-directional depending on interstimulus interval: QPS5 increases the excitability of motor cortex while QPS50 decreases it. The main advantage of QPS protocols is a high reproducibility of their effects, which exceeds that of other repetitive transcranial magnetic stimulation protocols. This review discusses the physiological effects and possible mechanisms for inducing neuroplasticity by QPS protocols. Special attention is paid to QPS application in clinical practice both for therapeutic neuromodulation and development of new biomarkers of functional brain state. Available QPS safety data are provided and previous works limitations as well as directions for further studies are analyzed.

  • Open Access

    Inflammatory Rasch-built Overall Disability Scale (I-RODS) for patients with Guillain–Barré syndrome, chronic inflammatory demyelinating polyneuropathy and polyneuropathy with monoclonal gammopathy of undetermined significance: linguacultural ratification in Russia for patients with chronic inflammatory demyelinating polyneuropathy

    by N. A. Suponeva, Alina S. Arestova, Е. А. Melnik, A. A. Zimin, A. M. Narbut, А. Yakubu, E. S. Shcherbakova, A. B. Zaytsev, D. A. Grishina, D. G. Yusupova, et al.

    Background. Chronic inflammatory demyelinating polyneuropathy (CIDP) is the most common type of dysimmune neuropathy, and it can lead to either permanent or temporary disability in about half of patients. Objective assessment of functional impairment is essential for monitoring therapeutic outcomes and disease progression in CIDP. The Inflammatory Rasch-built Overall Disability Scale (I-RODS) is one of the most valuable tools for assessing disability in CIDP patients and can be used in both clinical research and routine practice. In this article, we present the results of the validation process for this scale in Russian individuals with CIDP. Aim. To translate and validate the I-RODS for use in Russian patients with CIDP. Materials and methods. The study enrolled 50 cases of CIDP, evenly distributed between the typical variant and Lewis–Sumner syndrome. We performed linguocultural adaptation of the original version of the I-RODS using a standard protocol, after which we assessed the psychometric properties of the Russian version (i.e., its sensitivity, reliability and validity). Results. Psychometric evaluation demonstrated good reliability, sensitivity, and validity of the Russian I-RODS adaptation. Conclusion. We validated the Russian-language adaptation of the I-RODS, which can be applied in for both clinical practice and research.

  • Open Access

    Challenges in providing care to patients with disorders of consciousness in Russia: an online survey of healthcare professionals

    by L. A. Legostaeva, Наталья Александровна Супонева, D. V. Sergeev, E. G. Iazeva, Yu. V. Ryabinkina, E. V. Gnedovskaya, A. A. Belkin, M. V. Petrova, E. A. Kondratyeva, O. S. Zaitsev, et al.

    INTRODUCTION: Patients with disorders of consciousness (DoC) represent a complex patient cohort requiring a multidisciplinary approach. Despite the availability of modern national clinical guidelines (2023), real-world clinical practice in Russia continues to be challenged by the use of outdated terminology, insufficient implementation of validated diagnostic scales, and a lack of standardized management approaches, including pain assessment and management. This study was prompted by the need to assess the current situation and identify key issues to improve the quality of care for patients with DoC in Russia. OBJECTIVE: To assess the current practices, awareness, and key challenges faced by Russian healthcare professionals in the diagnosis, treatment, and management of patients with chronic DoC. MATERIALS AND METHODS: In 2024, an anonymous online survey of 204 medical and paramedical professionals (anesthesiologists, neurologists, rehabilitation specialists, psychologists, nursing staff) from various regions of Russia was conducted. The 47-item questionnaire covered demographic data, terminology used, diagnostic scales, treatment and rehabilitation methods, as well as approaches to pain assessment and management. RESULTS: Despite modern clinical guidelines, outdated terminology persists in practice: apallic syndrome (13.3 %), vegetative state. Only 62.9 % of respondents use the validated Coma Recovery Scale-Revised (CRS-R) for DoC diagnosis, while 77.1 % still use non-relevant scales (Glasgow Coma Scale, Full Outline of UnResponsiveness — FOUR). 30 % of respondents, including physicians responsible for diagnosis, use exclusively these non-relevant tools. Significant differences in approaches were identified among specialists of different profiles (intensivists, neurologists, rehabilitation specialists). The majority of respondents (83 %) acknowledge that DoC patients experience pain; however, the assessment methods (autonomic signs, grimacing) are not standardized and can be non-specific. CONCLUSIONS: The study results indicate insufficient awareness and fragmented implementation of modern standards for the diagnosis and management of patients with DoC in Russia. The findings highlight the necessity of developing and implementing educational programs for healthcare professionals aimed at standardizing terminology, promoting the use of validated diagnostic scales (CRS-R), and harmonizing approaches to pain management.

  • Diagnosis of the phenomenon of ‘covert cognition’ in patients with prolonged disorders of consciousness: clinical cases

    by A. N. Cherkasova, K. A. Yatsko, M. S. Kovyazina, N. A. Varako, Yu. V. Ryabinkina, E. I. Kremneva, M. V. Krotenkova, A. G. Brutyan, P. A. Fedin, N. A. Suponeva, et al.

    In recent decades, our understanding of patients with prolonged disorders of consciousness (PDOC) has expanded significantly thanks to the description of the phenomenon of ‘covert cognition.’ An individual approach is important in its diagnosis, involving the comparison of behavioural and instrumental data for each patient. In our country, research into this phenomenon is only just beginning to develop, which makes it important to accumulate cases of successful detection of various ‘covert’ signs of consciousness. This article presents clinical observations of two patients with PDOC. According to clinical assessment using specialised scales, the first patient was in a vegetative state/had unresponsive wakefulness syndrome. Using functional magnetic resonance imaging (fMRI) with a specially designed set of paradigms, the phenomenon of ‘covert cognition’ was detected in her (cerebral activation, partially correlated with the norm, in response to passive somatosensory, auditory non-verbal and verbal stimuli). The second patient, according to the clinical assessment, corresponded to a minimally conscious state ‘minus’. As a result of fMRI examination, instrumental confirmation of the preservation of certain aspects of consciousness (cerebral activation in response to auditory non-verbal and auditory verbal paradigms) was obtained. The use of a comprehensive multimodal personalised approach to the diagnosis of the phenomenon of ‘covert cognition’ and the possibilities of neurorehabilitation of patients based on the data obtained with its help are discussed.